Fallopian Tube Carcinoma Clinical Trials

62 clinical trials for Fallopian Tube Carcinoma across international registries, including 12 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• IGFBP-2 Vaccine to Prevent Ovarian Cancer Progression in Patients With Serologic Detection of Recurrence — RECRUITING · PHASE2
• The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas — RECRUITING · PHASE2
• Dual-Targeting CAR-NK Cells for Recurrent Ovarian Cancer (MSLN, FRα, MUC16) pt2 — RECRUITING · PHASE1
• Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF — RECRUITING · PHASE1
• REVITALIZE: RCT to Reduce Fatigue in Adults With Ovarian Cancer on PARP Inhibitors — RECRUITING · NA
• Study of Acute Normovolemic Hemodilution (ANH) in People With Ovarian Cancer Who Are Having Cytoreductive Surgery — RECRUITING · PHASE2
• Dual-Targeting CAR-NK Cells for Recurrent Ovarian Cancer (MSLN, FRα, MUC16) — RECRUITING · PHASE1
• Prospective Cohort Study of Germline Variant Carriers With BRCA1 or BRCA2 — RECRUITING
• Cryocompression With or Without Cilostazol for the Prevention of Paclitaxel-induced Neuropathy in Patients With Gynecological Cancers — RECRUITING · PHASE2
• ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation — RECRUITING
• RC48 Treatment for Platinum Sensitive Recurrent Ovarian Cancer With HER2 Expression — RECRUITING · PHASE2
• A Study of Maintenance DCVAC/OvCa After First-line Chemotherapy Added Standard of Care — RECRUITING · PHASE2
• Testing the Combination of the Study Drugs Cediranib and Olaparib in Recurrent Ovarian Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• Cediranib Maleate and Olaparib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Peritoneal Cancer or Recurrent Triple-Negative Breast Cancer — ACTIVE_NOT_RECRUITING · PHASE1
• National Cancer Institute "Cancer Moonshot Biobank" — ACTIVE_NOT_RECRUITING
• Standardized Extract of Cultured Lentinula Edodes Mycelia (AHCC®) in Ovarian Cancer Patients on Adjuvant Chemotherapy — ACTIVE_NOT_RECRUITING · PHASE2
• Prehabilitation Care for Women With Advanced Ovarian Cancer Receiving Neoadjuvant Chemotherapy — ACTIVE_NOT_RECRUITING · NA
• Feasibility of Saliva and Remote Monitoring of Active Cytomegalovirus (CMV) Infection and Symptoms During Ovarian Cancer Treatment — COMPLETED
• NM32-2668 in Adult Patients With Selected Advanced Solid Tumors — TERMINATED · PHASE1
• Body Surface Area-based vs Concentration-based Dosing of Cisplatin for Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Women With Advanced Ovarian Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies — TERMINATED · PHASE1
• NGS-based Germline and Somatic Genetic Test in Ovarian Carcinoma — ACTIVE_NOT_RECRUITING · PHASE4
• SCT-001 CAR T Cells Therapy for Relapsed and Refractory Ovarian Cancer — NOT_YET_RECRUITING · PHASE1
• HOT: HIPEC in Ovarian Cancer as Initial Treatment — ACTIVE_NOT_RECRUITING · PHASE2
• Cost of Cancer Risk Management in Women at Elevated Genetic Risk for Ovarian Cancer Who Participated on GOG-0199 — WITHDRAWN
• A Trial of Weekly Paclitaxel With Oncothermia and Weekly cisPlatin With Oncothermia in Patients With Recurrent or Persistent Ovarian Cancer — COMPLETED · PHASE1
• Factors Influencing Cascade Testing Among Women With Hereditary Gynecological Cancers and Their Relatives — COMPLETED
• Phase 1/2a/3 Evaluation of Adding AL3818 to Standard Platinum-Based Chemotherapy in Subjects With Recurrent or Metastatic Endometrial, Ovarian, Fallopian, Primary Peritoneal or Cervical Carcinoma (AL3818-US-002) — OTHER · PHASE3
• Hyperthermic Intraoperative Intraperitoneal Chemotherapy of Recurrent Ovarian Cancer - A Feasibility Study — TERMINATED · NA
• DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly ICLC, and IDO1 Inhibitor INCB024360 in Treating Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Remission — COMPLETED · PHASE1
• Neoadjuvant Chemotherapy in Epithelial Ovarian Cancer — OTHER · PHASE2
• A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors — COMPLETED · PHASE1
• First-Line Treatment of Bevacizumab, Carboplatin, and Paclitaxel in Treating Participants With Stage III-IV Ovarian, Primary Peritoneal, and Fallopian Tube Cancer — COMPLETED · PHASE2
• Lenvatinib and Weekly Paclitaxel for Patients With Recurrent Endometrial or Ovarian Cancer — COMPLETED · PHASE1
• Autologous Dendritic Cells Loaded With Autologous Tumor Associated Antigens for Treatment of Advanced Epithelial Ovarian Carcinomas — OTHER · PHASE2
• Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery — COMPLETED
• Carboplatin, Paclitaxel, Bevacizumab, and Veliparib in Treating Patients With Newly Diagnosed Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer — COMPLETED · PHASE1
• Intravital Microscopy in Evaluating Patients With Primary Peritoneal, Fallopian Tube, or Stage IA-IV Ovarian Cancer — COMPLETED · PHASE1
• Surgery or Chemotherapy in Recurrent Ovarian Cancer (SOC 1 Trial)? — OTHER · PHASE3
• Trial of Chemotherapy in Ovarian, Fallopian Tube and Peritoneal Carcinoma — COMPLETED · PHASE2
• Incidence of Cancer in Women at Increased Genetic Risk of Ovarian Cancer — COMPLETED
• Heated Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Peritoneal Cancer — COMPLETED · PHASE1
• Symptom Management in Patients With Recurrent or Persistent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer — OTHER · NA
• Evaluation of TRC105 in the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma — COMPLETED · PHASE2
• A6 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer — COMPLETED · PHASE2
• Photoacoustic Imaging in Detecting Ovarian or Fallopian Tube Cancer — WITHDRAWN · NA
• Belinostat in Treating Patients With Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer or Ovarian Low Malignant Potential Tumors — COMPLETED · PHASE2
• Biomarkers in Patients With Previously Untreated Invasive Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer — COMPLETED
• A Trial of Intravenous Denileukin Diftitox Plus Subcutaneous Pegylated IFNα-2A in Stage III or IV Ovarian Cancer — TERMINATED · PHASE2
• A Trial of Intravenous Denileukin Diftitox in Stage III or IV Ovarian Cancer — COMPLETED · PHASE2

Refine this search